Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4635-4643
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4635
Figure 2
Figure 2 Long-term overall survival in the liver resection group was significantly better than that in the transarterial chemoembolization group for solitary hepatocellular carcinomas with a diameter of no more than 6 cm. The survival benefit in the liver resection group increased further after 3 years. HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization.